A Magnetically Responsive Drug-Loaded Nanocatalyst with Cobalt-Involved Redox for the Enhancement of Tumor Ferrotherapy

Yuchu He,Xiaowei Li,Zhuo Li,Jiaxin Bian,Xinyue Zhang,Shipan Wei,Xuwu Zhang,Dawei Gao
DOI: https://doi.org/10.1039/d0cc03829f
IF: 4.9
2020-01-01
Chemical Communications
Abstract:Herein, cobalt-involved redox in a magnetically responsive drug-loaded nanocatalyst (PTX/Co-Lips@Fe3O4) was used to convert Fe(iii) to Fe(ii) for enhancing tumor ferrotherapy for the first time. Moreover, this work highlighted an "all in one" strategy: (1) targeting, chemotherapy, and ferrotherapy in one nanomedicine, and (2) a decrease in GSH quantity, increase in the quantity of efficient catalytic ions, and use of a magnetic field, all in one tumor ferrotherapy enhancement approach.
What problem does this paper attempt to address?